摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

Acenaphthoylacrylsaeure | 92964-72-2

中文名称
——
中文别名
——
英文名称
Acenaphthoylacrylsaeure
英文别名
——
Acenaphthoylacrylsaeure化学式
CAS
92964-72-2
化学式
C16H12O3
mdl
——
分子量
252.269
InChiKey
OLAKIVCWXCQXPN-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.76
  • 重原子数:
    19.0
  • 可旋转键数:
    3.0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.12
  • 拓扑面积:
    54.37
  • 氢给体数:
    1.0
  • 氢受体数:
    2.0

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    Acenaphthoylacrylsaeure4-磺酰胺基苯肼盐酸盐乙醇 为溶剂, 反应 48.0h, 以25%的产率得到4-[3-(1,2-dihydroacenaphthylen-5-yl)-6-oxo-1,6-dihydropyridazin-1-yl]benzene-1-sulfonamide
    参考文献:
    名称:
    Pyridazinone substituted benzenesulfonamides as potent carbonic anhydrase inhibitors
    摘要:
    A series of sulfonamide derivatives (2a-l) incorporating substituted pyridazinone moieties were investigated for the inhibition of two human cytosolic carbonic anhydrase isoforms, hCA I and hCA II. All these compounds, together with the clinically used sulfonamide acetazolamide were investigated as inhibitors of the physiologically relevant isozymes I and II. These sulfonamides showed very strong inhibition against all these isoforms with K-I's in the range of 0.98-8.5 nM which makes such molecules possible to be used as leads for discovery of novel effective CA inhibitors targeting other isoforms with medicinal chemistry applications. (C) 2016 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2015.12.016
  • 作为产物:
    描述:
    马来酸酐 在 aluminum (III) chloride 作用下, 以 1,1,2,2-四氯乙烷 为溶剂, 生成 Acenaphthoylacrylsaeure
    参考文献:
    名称:
    Pyridazinone substituted benzenesulfonamides as potent carbonic anhydrase inhibitors
    摘要:
    A series of sulfonamide derivatives (2a-l) incorporating substituted pyridazinone moieties were investigated for the inhibition of two human cytosolic carbonic anhydrase isoforms, hCA I and hCA II. All these compounds, together with the clinically used sulfonamide acetazolamide were investigated as inhibitors of the physiologically relevant isozymes I and II. These sulfonamides showed very strong inhibition against all these isoforms with K-I's in the range of 0.98-8.5 nM which makes such molecules possible to be used as leads for discovery of novel effective CA inhibitors targeting other isoforms with medicinal chemistry applications. (C) 2016 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2015.12.016
点击查看最新优质反应信息

文献信息

  • Pyridazinone substituted benzenesulfonamides as potent carbonic anhydrase inhibitors
    作者:Raed Yaseen、Deniz Ekinci、Murat Senturk、Alhamzah Dh. Hameed、Syed Ovais、Pooja Rathore、Mohammed Samim、Kalim Javed、Claudiu T. Supuran
    DOI:10.1016/j.bmcl.2015.12.016
    日期:2016.2
    A series of sulfonamide derivatives (2a-l) incorporating substituted pyridazinone moieties were investigated for the inhibition of two human cytosolic carbonic anhydrase isoforms, hCA I and hCA II. All these compounds, together with the clinically used sulfonamide acetazolamide were investigated as inhibitors of the physiologically relevant isozymes I and II. These sulfonamides showed very strong inhibition against all these isoforms with K-I's in the range of 0.98-8.5 nM which makes such molecules possible to be used as leads for discovery of novel effective CA inhibitors targeting other isoforms with medicinal chemistry applications. (C) 2016 Elsevier Ltd. All rights reserved.
查看更多